Business Context and Reporting Period
This Form 6-K filing by Prudential plc (the "Company") covers the month of December 2024, with the report dated December 18, 2024. The Company is a global provider of life and health insurance and asset management services operating in 24 markets across Asia and Africa. It holds dual primary listings on the Stock Exchange of Hong Kong and the London Stock Exchange.
Key Financial Metrics
This filing reports on a specific share buyback transaction rather than comprehensive financial performance metrics such as revenue, profit, or cash flow. The filing text does not provide a clear value for these operational metrics.
- Transaction Type: Purchase of own ordinary shares (5 pence each).
- Aggregate Shares Purchased: 938,953 shares.
- Average Price Paid: GBP 6.3598 per share.
- Price Range: Lowest GBP 6.2900; Highest GBP 6.4000.
- Intermediary: Barclays Securities Limited.
- Post-Transaction Shares in Issue: 2,660,600,367.
Material Changes
The primary material change reported is the reduction in the Company's share capital following the purchase of 938,953 shares on December 17, 2024. The Company intends to cancel these purchased shares. Consequently, the total number of voting rights in the Company is now 2,660,600,367.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, forward-looking outlook, or specific risk factors beyond standard regulatory compliance. The transaction was executed in accordance with shareholder authority granted at the 2024 Annual General Meeting and complies with the rules of the London Stock Exchange and the Hong Kong Code on Share Buy-backs.
Investor Verification Checklist
- Verify the updated total share count of 2,660,600,367 for calculating ownership percentages under FCA Disclosure Guidance and Transparency Rules.
- Confirm the cancellation of the 938,953 purchased shares to ensure accurate capital structure reporting.
- Review the full breakdown of individual trades via the provided RNS link for detailed execution analysis.
- Note that this filing does not contain quarterly or annual financial results; refer to Form 20-F for comprehensive financial data.